New-Generation Antidepressants, Suicide and Depressed Adolescents: How Should Clinicians Respond to Changing Evidence?
The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
The purpose of the present paper was to identify, from the voluminous literature on efficacy and safety in new-generation antidepressants (NGAs) with depressed children and adolescents, practical clinical strategies for acute phase treatment. To this end a pragmatic survey of studies and reviews was undertaken. Meta-analyses of randomized controlled trials of NGAs in depressed children and adolescents have noted a comparative lack of efficacy, and a weak but statistically significant increased risk of self-harm and suicidal thoughts. But NGA prescription rates and youth suicide rates are generally inversely related, and ensuing ‘black box’ warnings about NGAs, by deterring NGA prescribing, have possibly contributed to rising youth suicide rates. In moderate–severe depression, benefits for fluoxetine and possibly other NGAs demonstrably outweigh risks. NGAs are not present in adolescents who die by suicide. Concern about NGA risks must be balanced against risks of non-treatment. While mild depression entails regular review, psychoeducation, self-care strategies and psychological interventions, NGAs should be administered concurrently with psychological treatments if depression is moderate– to severe, or if mild depression persists. Patients should be warned about off-label status of NGAs in depression, serious side-effects such as ‘activation’, suicidality, emotional blunting and manic switches, the need for adherence and avoiding abrupt discontinuation. They should be monitored early and regularly. Better evidence is required regarding psychological treatments, clinical course, and clinical practice trends. In moderate–severe depression the risk of suicide if NGAs are not used may outweigh any risk of self-harm associated with them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 2004 black box warning that selective serotonin reuptake inhibitors might increase suicidal thinking and behavior resulted in a decline in antidepressant treatment in young people.136”
From Suicide in young people: screening, risk assessment, and intervention (2023) · cites this paper as [136]
Citations
Cites
Pine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753
Why we need observational studies to evaluate the effectiveness of health care
Black, N. (1996) · BMJ · doi:10.1136/bmj.312.7040.1215 · Cited by 1,598
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,058
Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Emslie, G. J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230069010 · Cited by 985
Depressed Adolescents Grown Up
Weissman, M. M. (1999) · JAMA · doi:10.1001/jama.281.18.1707 · Cited by 952
Sawyer, M. G., Arney, F. M., Baghurst, P. A., Clark, J. J., Graetz, B. W., Kosky, R. J., Nurcombe, B., Patton, G. C., Prior, M. R., Raphael, B., et al. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00964.x · Cited by 826
Research works printed but not linked: 21
- Hammad T, Results of the analysis of suicidality in pediatric trials of newer antidepressants
- Leon A, 1993, J Clin Psychiatry; 65, 2004, 915
- 10.1080/j.1440-1614.2006.01812.x · doi:10.1080/j.1440-1614.2006.01812.x
- 10.1080/j.1440-1614.2000.00691.x · doi:10.1080/j.1440-1614.2000.00691.x · Paper page
- Kirsch D, 2004, FDA testimony of Dr David Kirsch and Dr David Antonuccio on the efficacy of antidepressants in children
- Rothschild AJ, 1991, J Clin Psychiatry, 52, 491
- Teicher MH, 1990, Am J Psychiatry, 142, 207
- Department of Health and Human Services PHS, Food and Drug Administration, 1991, Psychopharmacological Drugs Advisory Committee
- European Medicines Agency, 2005, European Medicines Agency finalises review of antidepressants in children and adolescents
- Australian Adverse Drug Reactions Advisory Committee, 2004, Use of SSRI antidepressants in children and adolescents
- Breggin PR, 2004, Int J Risk Saf Med, 16, 31
- US Food and Drug Administration Clinical Review, 2006, Relationship between antidepressant drugs and suicidality in adults
- Mackay F, 1999, Br J Gen Pract, 49, 892
- Bell G, 2005, Q Essay, 18, 1
- Parker G, 2005, Q Essay, 19, 88
- Committee of Safety of Medicines, 2005, Selective serotonin reuptake inhibitors (SSRIs): overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents
- Shaffer D, 2005, Comprehensive textbook of psychiatry, vol II, 3262
- Rigioni GC, Drug utilization for selected antidepressants among children & adolescents in the US
- Mayer-Gross W, 1960, Clinical psychiatry
- Royal Australian and New Zealand College of Psychiatrists, Royal College of General Practitioners, and Royal Australasian College of Physicians, 2005, Aust Fam Physician, 34, 777
- 2003, Therapeutic Guidelines: Psychotropic
Cited by
Suicide in young people: screening, risk assessment, and intervention
Hughes, J. L., Horowitz, L. M., Ackerman, J. P., Adrian, M. C., Campo, J. V., & Bridge, J. A. (2023) · BMJ · doi:10.1136/bmj-2022-070630 · Cited by 135
Carvalho, A. F., Berk, M., Hyphantis, T. N., & McIntyre, R. S. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000357500 · Cited by 123
Are Adolescents Dying by Suicide Taking SSRI Antidepressants? A Review of Observational Studies
Dudley, M. J., Goldney, R. D., & Hadzi-Pavlovic, D. (2010) · Australasian Psychiatry · doi:10.3109/10398561003681319 · Cited by 37
Self-citationHetrick, S. E., Simmons, M., Thompson, A., & Parker, A. G. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.619161 · Cited by 29
Fountoulakis, K. Ν. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-14 · Cited by 31
Metadata
- Authors
- Dudley, M., Hadzi-Pavlovic, D., Andrews, D., & Perich, T.
- Affiliations
- UNSW Sydney (AU)
- Black Dog Institute, and School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia
- Black Dog Institute (AU)
- Corresponding author
- Dudley, Michael
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2008-01-01
- Volume
- 42
- Issue
- 6
- Pages
- 456-466
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2147818745
- Cited by
- 15
- References
- 99
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 0.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Health and Medical Research Council
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- adolescent depression, youth suicide, suicidality, fluoxetine, black box warning, antidepressant prescribing, treatment-resistant depression, off-label drug use, emotional blunting, manic switch, medication adherence, suicide prevention, psychoeducation
- MeSH terms
- Suicide Prevention, Adolescent, Child, Depressive Disorder, Humans, Suicide, Meta-Analysis as Topic, Treatment Outcome, Practice Guidelines as Topic, Risk Assessment, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New-Generation Antidepressants, Suicide and Depressed Adolescents: How Should Clinicians Respond to Changing Evidence? https://app.cochat.ai/papers/10.1080/00048670802050538
- The paper
- Dudley, M., Hadzi-Pavlovic, D., Andrews, D., & Perich, T. (2008). New-Generation Antidepressants, Suicide and Depressed Adolescents: How Should Clinicians Respond to Changing Evidence? Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/00048670802050538
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.